+140.1%
GOOGL vs MRNA
-67.9%
+208.0%
-44.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.8% | +5.4% | -3.6% | +1.5% |
| 7D | 0.0% | -1.1% | +1.1% | +0.1% |
| 30D | -1.4% | +126.1% | -127.5% | -8.8% |
| 3M | -5.3% | +190.0% | -195.4% | -15.5% |
| 6M | +9.8% | +157.2% | -147.4% | -1.0% |
| YTD | +8.4% | +388.2% | -379.8% | -10.1% |
| 1Y | +41.2% | +467.0% | -425.8% | +14.1% |
| 3Y | +149.6% | +36.1% | +113.5% | +129.6% |
| All | +140.1% | -67.9% | +208.0% | +132.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling